Article Versions Notes

Festuccia C, Mancini A, Gravina GL, Colapietro A, Vetuschi A, Pompili S, Ventura L, Delle Monache S, Iorio R, Del Fattore A, et al. Dual CXCR4 and E-Selectin Inhibitor, GMI-1359, Shows Anti-Bone Metastatic Effects and Synergizes with Docetaxel in Prostate Cancer Cell Intraosseous Growth. Cells. 2020; 9(1):32. https://doi.org/10.3390/cells9010032

Festuccia, Claudio, Andrea Mancini, Giovanni Luca Gravina, Alessandro Colapietro, Antonella Vetuschi, Simona Pompili, Luca Ventura, Simona Delle Monache, Roberto Iorio, Andrea Del Fattore, and et al. 2020. "Dual CXCR4 and E-Selectin Inhibitor, GMI-1359, Shows Anti-Bone Metastatic Effects and Synergizes with Docetaxel in Prostate Cancer Cell Intraosseous Growth" Cells 9, no. 1: 32. https://doi.org/10.3390/cells9010032

Festuccia, C., Mancini, A., Gravina, G. L., Colapietro, A., Vetuschi, A., Pompili, S., Ventura, L., Delle Monache, S., Iorio, R., Del Fattore, A., Fogler, W., & Magnani, J. (2020). Dual CXCR4 and E-Selectin Inhibitor, GMI-1359, Shows Anti-Bone Metastatic Effects and Synergizes with Docetaxel in Prostate Cancer Cell Intraosseous Growth. Cells, 9(1), 32. https://doi.org/10.3390/cells9010032